| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 12/31/2008 | CN101333256A Human antibodies that bind human il-12 and methods for producing |
| 12/31/2008 | CN101333174A N-bridged selective androgen receptor modulators and methods of use thereof |
| 12/31/2008 | CN101332295A Enteric-coated glucosinolates and beta-thioglucosidases |
| 12/31/2008 | CN101332236A Jinshile in-situ-forming eye gel |
| 12/31/2008 | CN101332208A Sodium hyaluronate in-situ-forming eye gel |
| 12/31/2008 | CN101332180A Melbex eye drops and preparation method thereof |
| 12/31/2008 | CN101332173A Betaxolol hydrochloride in-situ-forming eye gel |
| 12/31/2008 | CN101332172A Dipivefrin hydrochlorideusp in-situ-forming eye gel |
| 12/31/2008 | CN101332171A Sodium chloride in-situ-forming eye gel |
| 12/31/2008 | CN101332170A Carteolol hydrochloride in-situ-forming eye gel |
| 12/31/2008 | CN100447154C Use of HMG fragments as anti-inflammatory agents |
| 12/31/2008 | CN100446776C Superoxide anion decomposing agent |
| 12/31/2008 | CA2728386A1 Nasal and ophthalmic delivery of aqueous corticosteroid solutions |
| 12/31/2008 | CA2691520A1 Composition for ophthalmic disease associated with hypoxia or ischemia |
| 12/31/2008 | CA2691415A1 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
| 12/31/2008 | CA2689299A1 Synergistic combination of anthranilamide pyridinureas and benzamide derivatives |
| 12/30/2008 | US7470687 Aryl oximes |
| 12/30/2008 | US7470673 Using vector comprising nucleotide sequences coding atonal-associated polypetides as therapeutic tool in treating hearing impairment and inflammatory bone disorders; antiarthritic agents |
| 12/30/2008 | CA2351703C Novel 4-dedimethylaminotetracycline derivatives |
| 12/30/2008 | CA2327398C Methods and compositions for stabilizing acetylcholine compositions |
| 12/30/2008 | CA2312098C A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 12/25/2008 | US20080319013 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compounds |
| 12/25/2008 | US20080318986 Ddc Compositions |
| 12/25/2008 | US20080318980 USE OF 7-(PYRIMIDIN-4 YL)-IMIDAZO[1,2-a]PYRIMIDIN-5(1H)-ONES AS GSK-3BETA INHIBITORS |
| 12/25/2008 | US20080318965 Derivatives of Alpha2-Adrenergic Receptor Agonist |
| 12/25/2008 | US20080318960 PAR2-modulating compounds and their use |
| 12/25/2008 | US20080318939 Methods for treating ophthalmic disorders |
| 12/25/2008 | US20080318843 Device and Method for the Delivery of Drugs for the Treatment of Posterior Segment Disease |
| 12/25/2008 | US20080317890 Method for treating visual impairment through the prophylactic administration of a morinda citrifolia-based naturaceutical |
| 12/25/2008 | US20080317819 Iop lowering drug combination or non-combination loaded contact lens with zonal drug delivery areas |
| 12/25/2008 | US20080317750 Antibody antagonists of ve-cadherin without adverse effects on vascular permeability |
| 12/25/2008 | US20080317723 Lymphatic endothelial cells materials and methods |
| 12/25/2008 | US20080317721 Method for the Treatment of Retinopathy of Prematurity and Related Retinopathic Diseases |
| 12/24/2008 | WO2008156094A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient |
| 12/24/2008 | WO2008136034A3 Ophthalmic compositions for the treatment of ocular hypertension and glaucoma |
| 12/24/2008 | WO2008100807A3 Ophthalmic compositions containing a synergistic combination of three polymers |
| 12/24/2008 | WO2008098027A3 Treatment of ischemic retinal conditions with memantine |
| 12/24/2008 | WO2008014338A3 Antagonists of endothelial differentiation gene subfamily 3 (edg-3, s1p3) receptors for prevention and treatment of ocular disorders |
| 12/24/2008 | EP2004196A2 Ocular allergy treatments |
| 12/24/2008 | EP2004158A2 Use of inhibitors of jun n-terminal kinases to treat glaucoma |
| 12/24/2008 | EP1461306B1 Quaternary ammonium compounds and their use as antimuscarinic agents |
| 12/24/2008 | DE69922977C5 Neue Kristallmodifikation von Torasemid New crystal modification of torasemide |
| 12/24/2008 | CN101330914A Control of intraocular pressure using ALK5 modulation agents |
| 12/24/2008 | CN101328159A Taxone precursor anti-cancer drugs, medicinal composition and use thereof |
| 12/24/2008 | CN101327325A Ophthalmologic irrigation solutions and method |
| 12/24/2008 | CN101327322A Red eye virus eye-cleaning dew |
| 12/24/2008 | CN101327252A Decumbent corydalis tuber in situ forming eye gel |
| 12/24/2008 | CN101327238A Medicament composition for eye |
| 12/24/2008 | CN101327222A Bear's gall in situ forming eye gel |
| 12/24/2008 | CN101327219A Prednisolone acetate in situ forming eye gel |
| 12/24/2008 | CN101327216A Atropine sulfate in situ forming eye gel |
| 12/24/2008 | CN101327212A Bendazac lysine in situ forming eye gel |
| 12/24/2008 | CN101327197A Sustained release drug delivery devices |
| 12/24/2008 | CN101327181A Puerarin in situ forming eye gel |
| 12/24/2008 | CN100444897C Nano complex eye drops containing liposoluble compound drug and its preparing method |
| 12/24/2008 | CN100444839C Treatment of chemokine mediated diseases |
| 12/24/2008 | CA2692248A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient |
| 12/23/2008 | US7468385 Preterm labor, premature birth, dysmenorrhea, inappropriate secretion of vasopressin, congestive heart failure, arterial hypertension, liver cirrhosis, nephrotic syndrome and ocular hypertension; 3-(5-((3-chlorobenzyl)sulfanyl)-4-(3-methoxypropyl)-4H-1,2,4-triazol-3-yl)-N-(2-methoxybenzyl)propanamide |
| 12/23/2008 | US7468380 Nitrogen-containing aromatic derivatives |
| 12/23/2008 | US7468368 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 12/23/2008 | US7468360 Therapeutic amides and related compounds |
| 12/23/2008 | US7468276 Bloodless mammalian placenta for use in generating multipotent stem cells |
| 12/23/2008 | CA2386627C Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders |
| 12/23/2008 | CA2306393C Use of 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid for the manufacture of a medicament for treating non-allergic ophthalmic inflammatory disorders and for the prevention of ocular neovascularization |
| 12/23/2008 | CA2245267C Crystal form of n-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 12/18/2008 | WO2008154470A1 Nhibitor of the receptor activity of the s1p2 receptor for inhibiting pathological angiogenesis in the eye |
| 12/18/2008 | WO2008154286A2 Modulation of chemosensory receptors and ligands associated therewith |
| 12/18/2008 | WO2008154221A2 Modulation of chemosensory receptors and ligands associated therewith |
| 12/18/2008 | WO2008154129A1 Pharmaceutical compositions and method for treating, reducing, ameliorating, alleviating, or preventing dry eye |
| 12/18/2008 | WO2008153655A2 Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic fhv-1 infections, and preventing or treating conjunctivitis |
| 12/18/2008 | WO2008153027A1 Pyrroloquinoline derivative and use thereof |
| 12/18/2008 | WO2008130332B1 Subsituted sulphonamides, process for their preparation, pharmaceutical composition comprising thereof and their use |
| 12/18/2008 | WO2007096859A9 Protection of the retina against laser injury by adnf peptides such as nap and sal |
| 12/18/2008 | US20080312321 Therapeutic substituted cyclopentanes |
| 12/18/2008 | US20080312283 Use of Hydroxylamine Derivates for Inhibiting Vitrectomy-Induced Cataracts |
| 12/18/2008 | US20080312273 Quinoline Derivatives Having Vegf Inhibiting Activity |
| 12/18/2008 | US20080312242 7-aryl-3, 9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases |
| 12/18/2008 | US20080312219 Biologically active methylene blue derivatives |
| 12/18/2008 | US20080312182 Ophthalmic composition with hyaluronic acid and polymeric biguanide |
| 12/18/2008 | US20080311622 Activatable recombinant neurotoxins |
| 12/18/2008 | US20080311186 Composition Having Effect on Treatment and Prevention of Dry Eye Syndrome |
| 12/18/2008 | US20080311121 Antibody antagonists of ve-cadherin without adverse effects on vascular permeability |
| 12/18/2008 | US20080311118 Vascular endothelial cell growth factor antagonists and uses thereof |
| 12/18/2008 | US20080311107 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 12/18/2008 | CA2685066A1 Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic fhv-1 infections, and preventing or treating conjunctivitis |
| 12/17/2008 | EP2002841A1 Ophthalmic composition comprising xanthan gum and glucose |
| 12/17/2008 | EP2001833A1 Anti-diabetic cataract compounds and their uses |
| 12/17/2008 | EP2001466A2 Formulations and methods for vascular permeability-related diseases or conditions |
| 12/17/2008 | EP2001457A1 Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma |
| 12/17/2008 | EP2001438A2 Stable formulations, and methods of their preparation and use |
| 12/17/2008 | EP1843791A4 Treatment of degenerative diseases with the x-linked inhibitor of apoptosis |
| 12/17/2008 | EP1722780A4 A method of preventing or treating glaucoma |
| 12/17/2008 | EP1369119B1 Il-12 expression controlling agents |
| 12/17/2008 | CN101326287A RNAi-mediated inhibition of HIF1A for treatment of ocular angiogenesis |
| 12/17/2008 | CN101325963A Compstatin and analogs thereof for eye disorders |
| 12/17/2008 | CN101322867A Pleoptic instrument for treating ophthalmology department visual disturbance disease |
| 12/17/2008 | CN101322815A Capsules for clearing heat, nourishing yin, improving vision and blackening hair |
| 12/17/2008 | CN101322743A Formulation capable of repairing lesion and damnification of eye and improving asthenopia and preparation thereof |
| 12/17/2008 | CN101322731A Capsule for protecting eye and lowering blood sugar |
| 12/17/2008 | CN101322717A Medicament composition for preventing and treating eye diseases |